Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Wintrust Financial Corporation announced it will release its third quarter and year-to-date 2026 earnings results after market close on October 19, 2026, followed by a conference call on October 20. The company operates as a financial holding company with various banking and non-banking services, holding approximately $75 billion in assets.
Pliant Therapeutics, a Nasdaq-listed clinical-stage biotech company, announced the appointment of Dr. David Raben as Chief Medical Officer. Dr. Raben brings over 30 years of oncology drug development experience from leading roles at Bicara Therapeutics, Amgen, and Genentech. His expertise will support advancement of Pliant's lead integrin-targeting…
Lithium Argentina announced positive results from its Scoping Study on the Stage 2 expansion project at the Cauchari-Olaroz lithium brine operation in Argentina, aiming to increase production capacity by 45,000 tpa lithium carbonate equivalent (LCE) to a total of about 85,000 tpa. The study shows an after-tax NPV8% of $3.1 billion and IRR of 28.5%,…
Abivax SA announced that seven scientific abstracts covering data from its lead drug candidate obefazimod, used for treating moderately to severely active ulcerative colitis, will be presented at the United European Gastroenterology Week 2026. The data includes results from Phase 3 ABTECT Maintenance and Induction trials, long-term Phase 2 outcomes…
Corvus Pharmaceuticals has initiated a Phase 1b clinical trial for its investigational drug soquelitinib targeting hidradenitis suppurativa (HS), a chronic inflammatory skin disease. This trial marks the fourth clinical indication for soquelitinib, which is also being studied in Phase 3 for peripheral T cell lymphoma, and Phase 2 for atopic dermati…
QCR Holdings, Inc., a multi-bank holding company providing commercial and consumer banking services in the Midwest, will release its financial results for Q3 2026 on October 20, 2026. The company will host a conference call and webcast on October 21 to discuss the results with shareholders and analysts.
Scienture Holdings, Inc., a Nasdaq-listed pharmaceutical holding company, announced a 1-for-25 reverse stock split effective October 5, 2026. The reverse split aims to maintain compliance with Nasdaq's minimum bid price requirement and provide flexibility for future share issuance. The company’s stock will continue trading under the symbol SCNX, wi…
Medallion Bank announced the closing of its public offering of 2.2 million shares of Series G Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock priced at $25 per share, raising approximately $55 million. The bank plans to use the proceeds for general corporate purposes, including the potential redemption of its outstanding Series E Preferre…
Longeveron Inc., a Nasdaq-listed biotech company, announced its participation in three major investment conferences focused on longevity and aging. The company is advancing its lead investigational product, laromestrocel, a mesenchymal stem cell therapy showing promising Phase 2b clinical results for aging-related frailty and supportive new analyse…
ACM Research, Inc., a NASDAQ-listed supplier of semiconductor and advanced packaging processing solutions, announced its management's participation in the upcoming 18th Annual CEO Investor Summit 2026. The event is held alongside SEMICON West and provides a platform for investors and analysts to engage with semiconductor industry leaders. Presentat…
Progress Software, a Nasdaq-listed AI infrastructure software company, reported its fiscal third quarter 2026 financial results ended August 31, 2026. The company provides enterprise AI solutions emphasizing context and control for organizations. A conference call and webcast were held to discuss results and outlook.
TTM Technologies has finalized the acquisition of Epiq Design Solutions, a leader in AI-enabled software-defined radios and high-performance RF products used in signals intelligence and electronic warfare. This acquisition adds complementary technologies and a strong management team, accelerating TTM's vertical integration strategy in Aerospace & D…
Bassett Furniture Industries, Inc. announced financial results for the third quarter ended August 29, 2026, reporting a 3.4% increase in consolidated revenue to $82.8 million, driven by higher retail and wholesale sales. Operating income improved significantly to $2.8 million from $0.6 million a year ago, supported by tariff refunds from the U.S. S…
Monte Rosa Therapeutics, a clinical-stage biotech company specializing in molecular glue degrader medicines, will present results from its Phase 1 GFORCE-1 study of MRT-8102 in subjects with elevated cardiovascular disease risk. The data showcase safety and activity across multiple doses over four weeks, highlighting modulation of key pathogenic dr…
Bank OZK announced it will release its Q3 2026 earnings on October 20, 2026, followed by a conference call on October 21, 2026. The earnings release and related materials will be available on the bank's investor relations website. The call will include management commentary and a Q&A session.
Arhaus, Inc., a premium home furnishings brand, announced the appointment of K.C. Moss as its first Chief Digital Officer. Moss will lead the company's digital strategy, focusing on eCommerce growth, digital product experience, personalization, and client analytics. This move reflects Arhaus's commitment to expanding its brand reach and enhancing c…
Micron Technology announced record revenue and net income for fiscal 2026, with Q4 revenue reaching $54.23 billion and full-year revenue at $133.19 billion, reflecting significant growth from the previous year. The company highlights robust performance across business units, strong cash flows, and increased investments in technology and manufacturi…
FormFactor, Inc., a leading provider of semiconductor test and measurement technologies, announced that its management will participate in the upcoming 18th Annual CEO Investor Summit on October 13, 2026. The event enables investors and analysts to engage with management teams from key semiconductor industry companies in a round-robin meeting forma…
Photronics, Inc., a global leader in photomask technology for integrated circuits and flat panel displays, announced its participation in the upcoming 18th Annual CEO Investor Summit in San Francisco, a prestigious event for accredited investors and analysts to engage with company management.
The Brink's Company announced it agreed to divest NoteMachine/TestLink UK as part of the UK Competition and Markets Authority's fast-track Phase 1 review related to its acquisition of NCR Atleos. The divestiture was anticipated and included in financial forecasts, and the acquisition remains on schedule to close in early Q1 2027 with expected cost …
Masco's limited exposure to new-home construction and strong cash generation give it defensive characteristics that matter while housing remains soft. With a TTM EPS near $4.49, FCF of $1.13B and management accelerating a $300M buyback, the risk/reward looks attractive from current levels. This trade idea lays out an entry at $67.84, a $78 upside t…
Cardinal Health (CAH) looks buyable around $223.81. The business generates strong free cash flow ($4.525B) and sits on a $51.8B market cap with operational levers to defend margins. Valuation is not dirt-cheap on a P/E of ~30, but P/S of 0.2 and EV/EBITDA ~14.5 leave room if management executes on specialty and efficiency initiatives. Trade plan pr…
Liquidia plunged intraday on heavy volume, opening a tactical long opportunity. Yutrepia is already driving multi-hundred-million dollar sales and four consecutive profitable quarters; the legal fight with United Therapeutics is a material risk but not a guaranteed existential threat. This trade targets a rebound toward normalizing valuations while…
Lexaria (LEXX) is a micro-cap play with cash on the balance sheet greater than its market cap, an undervalued drug-delivery IP portfolio, and recent technical oversold conditions. This is a high-risk, event-driven trade: the plan is to enter at $3.06, use a tight stop near the 52-week low, and hold for major licensing or corporate-development catal…
Microsoft's Copilot has moved from experimental feature to a coherent go-to-market play across Office, Dynamics, and Azure. The company now has product bundles, enterprise sales motions, and pricing experiments that make meaningful ARR upside credible. This trade aims to buy that narrative, targeting a re-rating over the next 180 trading days while…
